Equities research analysts expect National Health Investors Inc (NYSE:NHI) to post sales of $79.81 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for National Health Investors’ earnings, with the lowest sales estimate coming in at $78.06 million and the highest estimate coming in at $80.82 million. National Health Investors posted sales of $74.92 million during the same quarter last year, which would indicate a positive year over year growth rate of 6.5%. The business is scheduled to report its next earnings report on Tuesday, November 5th.
According to Zacks, analysts expect that National Health Investors will report full year sales of $312.60 million for the current year, with estimates ranging from $305.00 million to $317.55 million. For the next year, analysts expect that the business will post sales of $332.97 million, with estimates ranging from $320.96 million to $345.10 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that follow National Health Investors.
National Health Investors (NYSE:NHI) last issued its earnings results on Thursday, August 8th. The real estate investment trust reported $0.92 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.37 by ($0.45). The business had revenue of $78.10 million for the quarter, compared to analyst estimates of $77.64 million. National Health Investors had a return on equity of 11.00% and a net margin of 50.71%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.38 EPS.
Separately, Zacks Investment Research lowered shares of National Health Investors from a “hold” rating to a “sell” rating in a research report on Saturday. Three research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $79.60.
National Health Investors stock opened at $81.77 on Wednesday. National Health Investors has a fifty-two week low of $70.54 and a fifty-two week high of $84.75. The company has a debt-to-equity ratio of 1.04, a quick ratio of 14.42 and a current ratio of 14.42. The stock has a market cap of $3.58 billion, a P/E ratio of 14.92, a price-to-earnings-growth ratio of 3.81 and a beta of 0.33. The firm’s fifty day moving average price is $81.61 and its 200-day moving average price is $79.09.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Monday, September 30th will be given a dividend of $1.05 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $4.20 annualized dividend and a dividend yield of 5.14%. National Health Investors’s dividend payout ratio (DPR) is presently 76.64%.
In related news, CIO Kevin Carlton Pascoe sold 900 shares of the business’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $82.46, for a total value of $74,214.00. Following the completion of the sale, the executive now owns 27,826 shares in the company, valued at approximately $2,294,531.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 5.11% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the stock. Marshall Wace North America L.P. bought a new position in shares of National Health Investors during the first quarter valued at about $31,000. Farmers National Bank purchased a new stake in National Health Investors during the 1st quarter valued at about $49,000. Krane Funds Advisors LLC purchased a new stake in National Health Investors during the 2nd quarter valued at about $58,000. Doyle Wealth Management bought a new position in National Health Investors during the 2nd quarter worth approximately $78,000. Finally, Tower Research Capital LLC TRC grew its position in National Health Investors by 648.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,259 shares of the real estate investment trust’s stock worth $176,000 after acquiring an additional 1,957 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
See Also: What is an Initial Coin Offering (ICO)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for National Health Investors and related companies with MarketBeat.com’s FREE daily email newsletter.